Company / Current Liabilities per Share
Edesa Biotech, Inc. Current Liabilities per Share History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.15
FY2021
5-year range
$0.03 / $0.33
FY2017-FY2021
Trend
-25.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 7 years, ranging from $0.02 in FY2014 to $0.33 in FY2018.
Based on SEC 10-K filings.
0.15 in FY2021 with a 5-year CAGR of +14.2%.
Improved from $0.33 to $0.15 over the past 3 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -22.7%
- 5-Year CAGR
- +14.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, current liabilities per share decreased 25.6% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.15 | -25.6% |
| FY2020 | $0.20 | -37.9% |
| FY2018 | $0.33 | +936.8% |
| FY2017 | $0.03 | -59.5% |
| FY2016 | $0.08 | -57.0% |
| FY2015 | $0.18 | +640.3% |
| FY2014 | $0.02 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026